Project number:
23
Risk of severe COVID-19 outcomes associated with atopic eczema and dupilumab
Risk of severe COVID-19 outcomes associated with atopic eczema and dupilumab is an OpenSAFELY project from The London School of Hygiene & Tropical Medicine. Every time a researcher runs their analytic code against patient data, it is audited in public here.
Workspaces
-
No workspaces
This project does not have any associated workspaces
Project timeline
-
Project created:
-
Code first run: No code has run